Shuta Tomida

12.0k citations

142 papers · 8.6k · 3 hit papers · h-index 39

Impact in

Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Dermatology top 0.5%
- Acne and Rosacea Treatments and Effects
- Dermatology and Skin Diseases

Papers in

Molecular Biology 72
- PI3K/AKT/mTOR signaling in cancer 15
- RNA modifications and cancer 12
Oncology 54
- HER2/EGFR in Cancer Research 12
- Colorectal Cancer Treatments and Studies 9

Co-authors: Takashi Takahashi (22 shared papers)Yasushi Yatabe (18 shared papers)Kiyoshi Yanagisawa (13 shared papers)Hirotaka Osada (11 shared papers)Tetsuya Mitsudomi (18 shared papers)Junichi Takamizawa (2 shared papers)Yoshio Tatematsu (4 shared papers)Hiroyuki Konishi (3 shared papers)
Journals: Cancer Science (14 papers)Cancer Research (12 papers)Scientific Reports (10 papers)PLoS ONE (6 papers)International Journal of Oncology (5 papers)
Partner nations: Japan United States United Kingdom

In The Last Decade

Shuta Tomida

133 papers receiving 8.5k citations

Shuta Tomida's Hit Papers

align trajectories log scale

Propionibacterium acnes Strain Populations in the Human Skin Microbiome Associated with Acne 2013 · 528 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Journal of Investigative Dermatology
2005 Cancer Research
2004 Cancer Research

Peers

Countries citing papers authored by Shuta Tomida

Since Specialization

Citations

This map shows the geographic impact of Shuta Tomida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuta Tomida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuta Tomida more than expected).

Fields of papers citing papers by Shuta Tomida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuta Tomida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuta Tomida. The network helps show where Shuta Tomida may publish in the future.

Co-authors

The 25 scholars most cited alongside Shuta Tomida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shuta Tomida Line = papers co-authored together Shuta Tomida links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Reduced Expression of the *let-7* MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival Cancer Research ·Junichi Takamizawa, Hiroyuki Konishi, Kiyoshi Yanagisawa, Shuta Tomida, Hirotaka Osada, Hideki Endoh, Tomoko Harano, Yasushi Yatabe, Masato Nagino, Yuji Nimura, Tetsuya Mitsudomi, Takashi Takahashi Hit paper breakdown →	2004	1938
2	A Polycistronic MicroRNA Cluster, miR-17-92 , Is Overexpressed in Human Lung Cancers and Enhances Cell Proliferation Cancer Research ·Yoji Hayashita, Hirotaka Osada, Yoshio Tatematsu, Hideki Yamada, Kiyoshi Yanagisawa, Shuta Tomida, Yasushi Yatabe, Katsunobu Kawahara, Yoshitaka Sekido, Takashi Takahashi Hit paper breakdown →	2005	1274
3	Propionibacterium acnes Strain Populations in the Human Skin Microbiome Associated with Acne Journal of Investigative Dermatology ·Sorel Fitz‐Gibbon, Shuta Tomida, Bor-Han Chiu, Lin Nguyen, Christine Du, Minghsun Liu, David Elashoff, Marie Crisel B. Erfe, Anya Loncaric, Jenny Kim, Robert L. Modlin, Jeff F. Miller, Erica Sodergren, Noah Craft, George M. Weinstock, Huiying Li Hit paper breakdown →	2013	528
4	Reduced expression of Dicer associated with poor prognosis in lung cancer patients Cancer Science ·Yoko Karube, Hisaaki Tanaka, Hirotaka Osada, Shuta Tomida, Yoshio Tatematsu, Kiyoshi Yanagisawa, Yasushi Yatabe, Junichi Takamizawa, Shinichiro Miyoshi, Tetsuya Mitsudomi, Takashi Takahashi	2005	476
5	Expression Profile–Defined Classification of Lung Adenocarcinoma Shows Close Relationship With Underlying Major Genetic Changes and Clinicopathologic Behaviors Journal of Clinical Oncology ·Toshiyuki Takeuchi, Shuta Tomida, Yasushi Yatabe, Takayuki Kosaka, Hirotaka Osada, Kiyoshi Yanagisawa, Tetsuya Mitsudomi, Takashi Takahashi	2006	248
6	NKX2-1/TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma Cancer Cell ·Tomoya Yamaguchi, Kiyoshi Yanagisawa, Ryoji Sugiyama, Yasuyuki Hosono, Yukako Shimada, Chinatsu Arima, Seiichi Kato, Shuta Tomida, Motoshi Suzuki, Hirotaka Osada, Takashi Takahashi	2012	207
7	Relapse-Related Molecular Signature in Lung Adenocarcinomas Identifies Patients With Dismal Prognosis Journal of Clinical Oncology ·Shuta Tomida, Toshiyuki Takeuchi, Yukako Shimada, Chinatsu Arima, Keitaro Matsuo, Tetsuya Mitsudomi, Yasushi Yatabe, Takashi Takahashi	2009	193
8	An Expanded Multilocus Sequence Typing Scheme for Propionibacterium acnes: Investigation of ‘Pathogenic’, ‘Commensal’ and Antibiotic Resistant Strains PLoS ONE ·Andrew McDowell, Emma Barnard, István Nagy, Anna Gao, Shuta Tomida, Huiying Li, E. Anne Eady, Jonathan H. Cove, Carl Erik Nord, Sheila Patrick	2012	182
9	Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in EGFR Mutation–Positive Non–Small Cell Lung Cancer Clinical Cancer Research ·Kohsuke Isomoto, Koji Haratani, Hidetoshi Hayashi, Shigeki Shimizu, Shuta Tomida, Takashi Niwa, Toshihide Yokoyama, Yasushi Fukuda, Yasutaka Chiba, Ryoji Kato, Junko Tanizaki, Kaoru Tanaka, Masayuki Takeda, Takashi Ogura, Tadashi Ishida, Akihiko Ito, Kazuhiko Nakagawa	2020	172
10	Lineage-Specific Dependency of Lung Adenocarcinomas on the Lung Development Regulator TTF-1 Cancer Research ·Hisaaki Tanaka, Kiyoshi Yanagisawa, Keiko Shinjo, Ayumu Taguchi, Ken Maeno, Shuta Tomida, Yukako Shimada, Hirotaka Osada, Takayuki Kosaka, Hideo Matsubara, Tetsuya Mitsudomi, Yoshitaka Sekido, Mitsune Tanimoto, Yasushi Yatabe, Takashi Takahashi	2007	165
11	Pan-Genome and Comparative Genome Analyses of Propionibacterium acnes Reveal Its Genomic Diversity in the Healthy and Diseased Human Skin Microbiome mBio ·Shuta Tomida, Lin Nguyen, Bor-Han Chiu, Jared Liu, Erica Sodergren, George M. Weinstock, Huiying Li	2013	148
12	Prognostic Model of Pulmonary Adenocarcinoma by Expression Profiling of Eight Genes As Determined by Quantitative Real-Time Reverse Transcriptase Polymerase Chain Reaction Journal of Clinical Oncology ·Hideki Endoh, Shuta Tomida, Yasushi Yatabe, Hiroyuki Konishi, Hirotaka Osada, Kohei Tajima, Hiroyuki Kuwano, Takashi Takahashi, Tetsuya Mitsudomi	2004	136
13	miR-375 Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer Cancer Research ·Eri Nishikawa, Hirotaka Osada, Yasumasa Okazaki, Chinatsu Arima, Shuta Tomida, Yoshio Tatematsu, Ayumu Taguchi, Yukako Shimada, Kiyoshi Yanagisawa, Yasushi Yatabe, Shinya Toyokuni, Yoshitaka Sekido, Takashi Takahashi	2011	115
14	Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients Oncogene ·Shuta Tomida, Katsumi Koshikawa, Yasushi Yatabe, Tomoko Harano, Nobuhiko Ogura, Tetsuya Mitsudomi, Masato Some, Kiyoshi Yanagisawa, Takashi Takahashi, Hirotaka Osada	2004	110
15	Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS -Mutant Lung Cancer Cancer Discovery ·Hidenori Kitai, Hiromichi Ebi, Shuta Tomida, Konstantinos V. Floros, Hiroshi Kotani, Yuta Adachi, Satoshi Oizumi, Masaharu Nishimura, Anthony C. Faber, Seiji Yano	2016	108
16	Roles of Achaete-Scute Homologue 1 in DKK1 and E-cadherin Repression and Neuroendocrine Differentiation in Lung Cancer Cancer Research ·Hirotaka Osada, Shuta Tomida, Yasushi Yatabe, Yoshio Tatematsu, Toshiyuki Takeuchi, Hideki Murakami, Yutaka Kondo, Yoshitaka Sekido, Takashi Takahashi	2008	83
17	The diversity and host interactions of Propionibacterium acnes bacteriophages on human skin The ISME Journal ·Jared Liu, Riceley Yan, Qiao Zhong, Sam Ngo, Nathanael J. Bangayan, Lin Nguyen, Timothy Lui, Minghsun Liu, Marie Crisel B. Erfe, Noah Craft, Shuta Tomida, Huiying Li	2015	82
18	Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer Scientific Reports ·Kenichi Suda, Isao Murakami, Kazuko Sakai, Hiroshi Mizuuchi, Shigeki Shimizu, Katsuaki Sato, Kenji Tomizawa, Shuta Tomida, Yasushi Yatabe, Kazuto Nishio, Tetsuya Mitsudomi	2015	74
19	MYBPH, a transcriptional target of TTF‐1, inhibits ROCK1, and reduces cell motility and metastasis The EMBO Journal ·Yasuyuki Hosono, Tomoya Yamaguchi, Eri Mizutani, Kiyoshi Yanagisawa, Chinatsu Arima, Shuta Tomida, Yukako Shimada, Michiyo Hiraoka, Seiichi Kato, Kohei Yokoi, Motoshi Suzuki, Takashi Takahashi	2011	72
20	Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR -Mutant Non–Small Cell Lung Cancer Cells Molecular Cancer Research ·Kei Namba, Kazuhiko Shien, Yuta Takahashi, Hidejiro Torigoe, Hiroki Sato, Takahiro Yoshioka, Tatsuaki Takeda, Eisuke Kurihara, Yusuke Ogoshi, Hiromasa Yamamoto, Junichi Soh, Shuta Tomida, Shinichi Toyooka	2018	71

About Shuta Tomida

Shuta Tomida is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 142 papers that have together received 8.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (40 papers), Cancer Genomics and Diagnostics (17 papers), PI3K/AKT/mTOR signaling in cancer (15 papers), HER2/EGFR in Cancer Research (12 papers), RNA modifications and cancer (12 papers), Cancer Mechanisms and Therapy (10 papers), Colorectal Cancer Treatments and Studies (9 papers) and Acne and Rosacea Treatments and Effects (8 papers). The work is most often cited by research in Cancer Research (4.2k citations), Dermatology (801 citations), Molecular Biology (5.7k citations), Oncology (1.8k citations) and Pulmonary and Respiratory Medicine (1.6k citations). Shuta Tomida has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Takashi Takahashi, Yasushi Yatabe, Kiyoshi Yanagisawa, Hirotaka Osada, Tetsuya Mitsudomi, Junichi Takamizawa, Yoshio Tatematsu, Hiroyuki Konishi, Hideki Endoh and Masato Nagino. Their work appears in journals such as Cancer Science, Cancer Research, Scientific Reports, PLoS ONE and International Journal of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Shuta Tomida

Impact in

Papers in i

In The Last Decade

Shuta Tomida

Shuta Tomida's Hit Papers

Peers

Countries citing papers authored by Shuta Tomida

Fields of papers citing papers by Shuta Tomida

All Works

About Shuta Tomida

Explore authors with similar magnitude of impact

Papers in